Trial Profile
An uncontrolled intervention trial on the effect of denosumab on QOL in patients with rheumatoid arthritis
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 17 May 2019
Price :
$35
*
At a glance
- Drugs Denosumab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 15 May 2019 Status changed from not yet recruiting to recruiting.
- 05 Mar 2018 New trial record